A novel dual-release scaffold for fluorescent labels improves cyclic immunofluorescence

Thorge Reiber1,2, Christian Dose1, Dmytro A Yushchenko1

  • 1Department of Chemical Biology, Miltenyi Biotec GmbH Friedrich-Ebert Straße 68 Bergisch Gladbach 51429 Germany dmytroy@miltenyi.com.

PubMed

Insights

Researchers developed new fluorescent labels for cyclic immunofluorescence. These labels improve signal erasure, enabling more cycles for high-content imaging in cell biology and therapy development.

Area of Science:

  • Cell Biology
  • Biotechnology
  • Immunology

Background:

  • Cyclic immunofluorescence generates high-content imaging data for cell biology and therapeutics.
  • Fluorescent labels are crucial for immunofluorescence quality and multiplexing capabilities.
  • Current labels face limitations in signal erasure efficiency, restricting the number of staining cycles.

Purpose of the Study:

  • To develop a novel fluorescent labelling strategy for enhanced cyclic immunofluorescence.
  • To create labels with improved brightness and efficient signal erasure.
  • To advance multiplexed cyclic immunofluorescence for deeper biological insights.

Main Methods:

  • Antibodies were conjugated to a novel scaffold for enzymatic fluorophore cleavage.
  • The scaffold comprised dextran decorated with single-stranded DNA (ssDNA).
  • Dual enzymatic cleavage mechanisms (DNase and dextranase) were employed for signal erasure.

Main Results:

  • The developed fluorescent labels demonstrated specific staining and high brightness.
  • Labels performed effectively in flow cytometry and fluorescence microscopy.
  • Dual enzymatic degradation significantly improved signal erasure from labelled epitopes.

Conclusions:

  • The novel dual-release fluorescent labels enhance cyclic immunofluorescence.
  • These labels offer high brightness and efficient, specific signal erasure.
  • The strategy is expected to advance multiplexed cyclic immunofluorescence and cell biology research.

Related Concept Videos